Search





Search





Markets
/
Stocks
/
nasdaq-odtx
/

Odyssey Therapeutics Ord Shs (Proposed)

ODTX

Add to Watchlist

18.060USD

0.0000.00%

Close 06/26, 16:00（ET）Quotes delayed by 15 min

128.67MMarket Cap

LossP/E TTM

Odyssey Therapeutics Ord Shs (Proposed)

18.060

0.0000.00%

Earnings Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Earnings Income Statement Balance Sheet Cash Flow Statement

You can access the annual and quarterly cash flow statements of Odyssey Therapeutics Ord Shs (Proposed) to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2024Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---41.03M

---34.29M

Net income from continuing operations

---38.26M

---35.93M

Operating gains losses

--1.17M

--1.29M

Other non-cash items

--583.00K

---157.00K

Change in working capital

---7.19M

---2.54M

-Change in prepaid expenses

--3.00K

---1.23M

-Change in other current assets

---1.69M

--1.83M

Cash from non-recurring investing activities

Cash from operating activities

---41.03M

---34.29M

Investing cash flow

Net cash from continuing investing activities

--148.00K

--265.00K

Capital expenditures

--148.00K

--265.00K

Net cash flow from disposal of fixed assets

--148.00K

--265.00K

Net cash flow from investment products

--34.95M

--47.41M

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

--34.80M

--47.14M

Financing cash flow

Cash flow from continuous financing activities

--484.00K

--6.82M

Net cash flow from debt Issuance/repayment

---24.00K

----

Proceeds from stock option exercised by employees

--651.00K

--357.00K

Net cash flow from other financing activities

---143.00K

---1.01M

Net cash from non-recurrent financing activities

Net cash from financing activities

--484.00K

--6.82M

Net cash flow

Beginning cash balance

--44.90M

--42.65M

Current period cash flow changes

---5.72M

--19.70M

Effect of exchange rate changes

--24.00K

--30.00K

Ending cash balance

--114.06M

--62.35M

Free cash flow

---41.18M

---34.55M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

